CytoDyn Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CytoDyn Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-08-31 was $21.00K.
- CytoDyn Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-02-28 was $21.00K.
- CytoDyn Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-11-30 was $200.00K, a 1900.00% increase year-over-year.
- CytoDyn Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-08-31 was $189.00K.
- CytoDyn Inc. stock issued during period, value, stock options exercised for fiscal 2026 was $149.00K, a 40.57% increase from fiscal 2025.
- CytoDyn Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $106.00K.
- CytoDyn Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $390.00K, a 78.78% decline from fiscal 2021.
- CytoDyn Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $1.84M, a 67.20% decline from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-05-31 | $149.00K 10-K · filed 2026-08-31 | |
| 2025-08-31 | $21.00K S-1 · filed 2026-04-22 | |
| 2025-05-31 | $106.00K 10-K · filed 2026-08-31 | |
| 2025-02-28 | $21.00K S-1 · filed 2026-04-22 | |
| 2022-05-31 | $390.00K 10-K · filed 2023-09-14 | |
| 2021-11-30 | $200.00K 10-Q · filed 2023-04-10 | |
| 2021-08-31 | $189.00K 10-Q · filed 2023-04-10 | |
| 2021-05-31 | $1.84M 10-K · filed 2022-08-15 | |
| 2021-02-28 | $1.78M 10-Q · filed 2022-04-11 | |
| 2020-11-30 | $10.00K 10-Q · filed 2022-04-11 | |
| 2020-08-31 | -$39.00K 10-Q · filed 2022-04-11 | |
| 2020-05-31 | $5.60M 10-K · filed 2022-08-15 | |
| 2020-02-29 | $54.00K 10-Q · filed 2021-04-14 | |
| 2019-11-30 | -$8.00K 10-Q · filed 2021-01-08 | |
| 2019-08-31 | $0.00 10-Q · filed 2020-01-09 | |
| 2012-05-31 | $326.90K 10-K · filed 2013-08-29 |